Improved tandem mass spectrometry (MS/MS) derivatized method for the detection of tyrosinemia type I, amino acids and acylcarnitine disorders using a single extraction process

被引:22
作者
Dhillon, Kuldeep S. [1 ]
Bhandal, Ajit S. [1 ]
Aznar, Constantino P. [1 ]
Lorey, Fred W. [1 ]
Neogi, Partha [1 ]
机构
[1] Calif Dept Publ Hlth, Genet Dis Lab Branch, Richmond, CA 94804 USA
关键词
Tandem mass spectrometry; Genetic disease screening; Tyrosinemia type I; Succinylacetone; Newborn screening; Dried blood spot; DRIED BLOOD SPOTS; SUCCINYLACETONE;
D O I
10.1016/j.cca.2010.12.028
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Succinylacetone (SUAC). a specific marker for tyrosinemia type I (Tyr I) cannot be detected by the routine LC-MS/MS screening of amino acids (AA) and acylcarnitines (AC) in newborns. The current derivatized methods require double extraction of newborn dried blood spots (DBS); one for AA and AC and the second for SUAC from the blood spot left after the first extraction. We have developed a method in which AA, AC and SUAC are extracted in a single extraction resulting in significant reduction in labor and assay time. Methods: The 3.2 mm DBS were extracted by incubating at 45 degrees C for 45 min with 100 mu l of acetonitrile (ACN)-water-formic acid mixture containing hydrazine and stable-isotope labeled internal standards of AA, AC and SUAC. The extract was derivatized with n-butanolic-HCl and analyzed by LC-MS/MS. Results: The average inter-assay CVs for. AA, AC and SUAC were 10.1. 10.8 and 7.1% respectively. The extraction of analytes with ACN-water mixture showed no significant difference in their recovery compared to commonly used solvent MeOH. The concentration of hydrazine had considerable impact on SUAC extraction. Conclusion: We developed a new MS/MS derivatized method to detect AA/AC/ SUAC in a single extraction process for screening Tyr I along with disorders of AA and AC. Published by Elsevier B.V.
引用
收藏
页码:873 / 879
页数:7
相关论文
共 13 条
[1]   Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots [J].
Allard, P ;
Grenier, A ;
Korson, MS ;
Zytkovicz, TH .
CLINICAL BIOCHEMISTRY, 2004, 37 (11) :1010-1015
[2]   Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns [J].
Chace, DH ;
Kalas, TA ;
Naylor, EW .
CLINICAL CHEMISTRY, 2003, 49 (11) :1797-1817
[3]   Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters [J].
Chace, Donald H. ;
Lim, Timothy ;
Hansen, Christina R. ;
De Jesus, Victor R. ;
Hannon, W. Harry .
CLINICA CHIMICA ACTA, 2009, 407 (1-2) :6-9
[4]  
Holme E, 2000, Clin Liver Dis, V4, P805, DOI 10.1016/S1089-3261(05)70142-2
[5]  
Holme Elisabeth, 1995, Current Opinion in Pediatrics, V7, P726
[6]   TRYOSINAEMIA TYPE-I - AN UPDATE [J].
KVITTINGEN, EA .
JOURNAL OF INHERITED METABOLIC DISEASE, 1991, 14 (04) :554-562
[7]   The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs [J].
la Marca, Giancarlo ;
Malvagia, Sabrina ;
Pasquini, Elisabetta ;
Innocenti, Marzia ;
Fernandez, Maira Rebollido ;
Donati, Maria Alice ;
Zammarchi, Enrico .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2008, 22 (06) :812-818
[8]  
LABERGE C, 1969, AM J HUM GENET, V21, P36
[9]   Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I [J].
Magera, MJ ;
Gunawardena, ND ;
Hahn, SH ;
Tortorelli, S ;
Mitchell, GA ;
Goodman, SI ;
Rinaldo, P ;
Matern, D .
MOLECULAR GENETICS AND METABOLISM, 2006, 88 (01) :16-21
[10]  
Mitchell G.A., 2001, METABOLIC MOL BASES, V8th, P1777